Ocular Hypertension Completed Phase 3 Trials for Dorzolamide (DB00869)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03257813Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)Treatment
NCT00576342Patient Preference StudyTreatment
NCT00546286A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)Treatment
NCT00878917Equivalence Study of Dorzolamide 2% Eye Drops SolutionTreatment
NCT00314171A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT00333125A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionTreatment